Clinical Trials on Lymphatic Malformation in Austria
Total 756 results
-
Novartis PharmaceuticalsTerminatedSolid Tumors and LymphomasUnited States, Australia, Netherlands, Canada, Germany, Switzerland, Japan, Spain
-
Eli Lilly and CompanyCompletedMantle-Cell LymphomaAustralia, France, Germany, Netherlands
-
Aptevo TherapeuticsCompletedChronic Lymphocytic Leukemia (CLL)United States, Austria, Germany, Poland, Spain
-
AmgenCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy, United Kingdom, Germany, France
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
Dutch Childhood Oncology GroupCompletedLeukemiaUnited States, United Kingdom, Belgium, Italy, Germany, Austria, Ireland, Netherlands, France, Sweden, Czech Republic
-
AbbVie (prior sponsor, Abbott)CompletedChronic Lymphocytic LeukemiaUnited States, Australia, Israel, Poland, Ukraine
-
Eli Lilly and CompanyCompletedT-Cell Lymphoma | B-Cell LymphomaMexico, United States, Australia, Brazil, Peru
-
Spectrum Pharmaceuticals, IncTerminatedPeripheral T-cell LymphomaBelgium, Spain, United States, Australia, France, Israel, Canada, United Kingdom, New Zealand, Italy, Ireland, Poland, Puerto Rico
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany, Austria
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
CelgeneWithdrawnLymphoma, B-CellKorea, Republic of, United States, Spain, Belgium, Taiwan, United Kingdom, Austria, France
-
AmgenNo longer availableRelapsed/Refractory B-Precursor Acute Lymphoblastic LeukemiaUnited States, Italy, Germany, Austria, France, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompletedALK-activated TumorsFrance, Spain, Germany, Italy, Korea, Republic of, Canada, Australia, United Kingdom, Netherlands, United States
-
Amgen Research (Munich) GmbHCompletedAcute Lymphoblastic LeukemiaUnited States, Germany, Austria, Canada, France, Italy, Netherlands
-
Histiocyte SocietyCompletedChildhood Langerhans Cell HistiocytosisCanada, United Kingdom, United States, France, Germany, Austria, Ireland, Sweden, Italy, Argentina
-
Seagen Inc.Bristol-Myers SquibbActive, not recruitingHodgkin LymphomaUnited States, Australia, Czechia, Italy, Spain, Poland
-
Hoffmann-La RocheCompletedDiffuse Large B-cell Lymphoma | High-Grade B-cell LymphomaUnited States, Spain, Australia, Denmark
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Canada
-
Lymphoma Study AssociationInstitute of Cancer Research, United Kingdom; Australasian Leukaemia and Lymphoma... and other collaboratorsCompletedFollicular LymphomaFrance, Thailand, Belgium, Spain, Argentina, Australia, Brazil, Colombia, Denmark, Netherlands, New Zealand, Peru
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Australia, Canada
-
BioCryst PharmaceuticalsCompletedChronic Lymphocytic Leukemia (CLL)United States, Australia
-
Kite, A Gilead CompanyCompletedRefractory Large B-cell LymphomaUnited States
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Australia
-
Hoffmann-La RocheRecruitingLymphomaKorea, Republic of, United States, Spain, France, Brazil, China, Canada, Australia, Sweden, Taiwan, Italy, United Kingdom
-
Gilead SciencesTerminatedFollicular LymphomaSpain, Italy, France, Poland, Israel, United Kingdom, Czechia, Romania, Australia, Canada
-
Ascentage Pharma Group Inc.RecruitingWaldenstrom MacroglobulinemiaUnited States, China, Australia
-
University College, LondonUniversity of Miami; Takeda; European Organisation for Research and Treatment... and other collaboratorsRecruitingHodgkin LymphomaUnited Kingdom, New Zealand, Australia, United States, Belgium, Spain
-
Bristol-Myers SquibbCompletedHodgkin DiseaseCanada, United States, Belgium, Austria, Czechia, Germany, Italy, Netherlands, Spain, United Kingdom
-
AbbVieF. Hoffmann-La Roche Ltd; German CLL Study Group (GCLLSG); Dana-Farber Cancer...RecruitingChronic Lymphocytic Leukemia (CLL)United States, Australia, Austria, Bulgaria, Germany, Italy, Spain, Israel, Brazil, Romania, United Kingdom
-
Hoffmann-La RocheRecruitingLymphoma, Non-HodgkinUnited States, Belgium, Australia, Denmark, Italy, Spain, France, United Kingdom
-
Therapeutic Advances in Childhood Leukemia ConsortiumEnzon Pharmaceuticals, Inc.TerminatedLymphoblastic Leukemia, Acute, Childhood | Leukemia, Lymphoblastic, Acute | Lymphoblastic Leukemia, Acute | Leukemia, Lymphoblastic, Acute, T CellUnited States, Australia
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, Hungary, Belgium, United Kingdom, France, Australia, Turkey, Croatia, Italy, Poland, Canada, Greece, Czechia, Ireland, Russian Federation, Spain, Portugal, Romania
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Lymphoma Study AssociationCompletedLymphoma, Large-Cell, DiffuseUnited States, Australia, Belgium, Czechia, Finland, Germany, Israel, Sweden, Switzerland, United Kingdom
-
The Lymphoma Academic Research OrganisationCelgeneActive, not recruitingRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaFrance, Denmark, United Kingdom, Austria, Belgium
-
BiogenCompletedNon-Hodgkin's LymphomaSweden, Czech Republic, France, Russian Federation, Turkey, United Kingdom, Germany, Lithuania, Romania, United States, Austria
-
Epizyme, Inc.Swedish Cancer InstituteTerminatedFollicular LymphomaUnited States
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia
-
BioCryst PharmaceuticalsCompletedCutaneous T-cell Lymphoma (CTCL),United States, Australia, Germany, Italy, Spain, France, Austria, Finland, Switzerland, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
CRISPR Therapeutics AGActive, not recruitingB-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALLUnited States, Spain, Canada, France, Germany, Australia
-
Kite, A Gilead CompanyRecruitingHigh-risk Large B-cell Lymphoma (LBCL)United States, Austria, Spain, Italy, Australia, Germany, Netherlands, Canada, Portugal, United Kingdom, France
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
Natera, Inc.Children's Hospital of Philadelphia; Montefiore Medical Center; University of... and other collaboratorsCompletedPrader-Willi Syndrome | DiGeorge Syndrome | 22q11 Deletion Syndrome | Angelman Syndrome | Trisomy 21 | Trisomy 18 | Trisomy 13 | Monosomy X | Sex Chromosome Abnormalities | 1p36 Deletion Syndrome | Cri-du-Chat SyndromeUnited States, Australia, Ireland, Spain, Sweden, United Kingdom
-
Marker Therapeutics, Inc.RecruitingHodgkin Lymphoma | Non Hodgkin Lymphoma | Hodgkin Lymphoma, Adult | Non-Hodgkin Lymphoma, Adult | Non-Hodgkin Lymphoma, Refractory | Non-Hodgkin Lymphoma, Relapsed | Hodgkin's Lymphoma, Relapsed, AdultUnited States
-
Aarhus University HospitalGCP-unit at Aarhus University Hospital, Aarhus, DenmarkCompletedLymphoma, T-Cell, PeripheralNorway, Belgium, Finland, Denmark, Austria, Czechia, Portugal, Germany, Netherlands, Poland, Sweden